infection and vaccination status of children aged 6 months-12 years: Time for mass vaccination

Basit Öğe Kaydı
dc.authorscopusid36165893600
dc.authorscopusid6601976056
dc.authorscopusid55332319400
dc.authorscopusid55332236300
dc.authorscopusid54791156900
dc.contributor.authorNalbanto?lu, Burçin
dc.contributor.authorDonma, Mustafa Metin
dc.contributor.authorÖzdilek, Burcu
dc.contributor.authorKarasu, Erkut
dc.contributor.authorNalbantoğlu, Ayşin
dc.date.accessioned2022-05-11T14:37:12Z
dc.date.available2022-05-11T14:37:12Z
dc.date.issued2013
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractObjective: This study was designed to determine the current age-related hepatitis A virus (HAV) seroprevalance, vaccination status of children and to evaluate the epidemiological shift in HAV serostatus living in Tekirda?, which is located in Thrace region, the European part of Turkey. Methods: Children 6 months-12 years of age with simple health problems were included. Blood samples were studied for HAV IgM and IgG collectively. A questionnaire addressing several characteristics of subjects was administered to obtain basic descriptive data on HAV epidemiology. Vaccination status of the children was recorded according to the immunization cards. Findings: The overall anti-HAV IgM and anti-HAV IgG prevalance in children aged 6 months - 12 years was 3.3% and 25.4% respectively. Maximum hepatitis A IgM positivity was in the 7-12 years age group 4.8% (n= 12; P<0.001) and maximum hepatitis A IgG positivity in the same age group was 34% (n=85; P<0.001). HAV vaccination rate among patients aged more than 2 years was 11.03%. HAV IgG seroprevalance was higher in children of low monthly income families (36.1%, n=78; P<0.001) than in the intermediate (17%, n=31) and high income families (11.1%, n=6). Conclusion: These results indicate a shift in Hepatitis A seroprevalance when compared with the previous studies. As HAV infection in childhood is decreasing, the pool of susceptible adolescents and young adults is increasing. Introduction of hepatitis A vaccination into the national immunization schedule of Turkey should be considered. © 2013 by Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, All rights reserved.
dc.identifier.endpage280
dc.identifier.issn2008-2142
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84878666860
dc.identifier.scopusqualityQ3
dc.identifier.startpage276
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8618
dc.identifier.volume23
dc.indekslendigikaynakScopus
dc.institutionauthorNalbanto?lu, Burçin
dc.institutionauthorDonma, Mustafa Metin
dc.institutionauthorÖzdilek, Burcu
dc.institutionauthorKarasu, Erkut
dc.language.isoen
dc.publisherKowsar Medical Publishing Company
dc.relation.ispartofIranian Journal of Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHepatitis
dc.subjectHepatitis A Virus
dc.subjectImmunization
dc.subjectVaccination
dc.subjecthepatitis A vaccine
dc.subjectimmunoglobulin G antibody
dc.subjectimmunoglobulin M antibody
dc.subjectvirus antibody
dc.subjectage distribution
dc.subjectarticle
dc.subjectchild
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectgeographic distribution
dc.subjecthepatitis A
dc.subjecthuman
dc.subjectinfant
dc.subjectlowest income group
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmass immunization
dc.subjectonset age
dc.subjectpreschool child
dc.subjectresidential area
dc.subjectschool child
dc.subjectseroprevalence
dc.subjectTurkey (republic)
dc.titleinfection and vaccination status of children aged 6 months-12 years: Time for mass vaccination
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu